Cite
HARVARD Citation
Rucinska, M. et al. (n.d.). SHARP hypofractionated stereotactic radiotherapy is low and intermediate-risk prostate carcinoma patients – PSA outcome. European journal of cancer. pp. S193-S194. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Rucinska, M. et al. (n.d.). SHARP hypofractionated stereotactic radiotherapy is low and intermediate-risk prostate carcinoma patients – PSA outcome. European journal of cancer. pp. S193-S194. [Online].